88 related articles for article (PubMed ID: 16524252)
1. TNFalpha increases in vitro migration of human HPV18-positive SW756 cervical carcinoma cells.
Hidalgo K; Rojas IG; Penissi AB; Rudolph MI
Biocell; 2005 Dec; 29(3):303-11. PubMed ID: 16524252
[TBL] [Abstract][Full Text] [Related]
2. Interaction of estrogen and tumor necrosis factor alpha in endothelial cell migration and early stage of angiogenesis.
Florian M; Florianova L; Hussain S; Magder S
Endothelium; 2008; 15(5-6):265-75. PubMed ID: 19065318
[TBL] [Abstract][Full Text] [Related]
3. [Antisense targeting to human papillomavirus 18 E6/E7 affects the proliferation and apoptosis of human cervical carcinoma: an in vitro experiment with HeLa cells].
Sima N; Kong DB; Wang W; Lu YP; Wang SX; Ma D
Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(23):1618-21. PubMed ID: 17803852
[TBL] [Abstract][Full Text] [Related]
4. The influence of mast cell mediators on migration of SW756 cervical carcinoma cells.
Rudolph MI; Boza Y; Yefi R; Luza S; Andrews E; Penissi A; Garrido P; Rojas IG
J Pharmacol Sci; 2008 Feb; 106(2):208-18. PubMed ID: 18296861
[TBL] [Abstract][Full Text] [Related]
5. Antitumor action of curcumin in human papillomavirus associated cells involves downregulation of viral oncogenes, prevention of NFkB and AP-1 translocation, and modulation of apoptosis.
Divya CS; Pillai MR
Mol Carcinog; 2006 May; 45(5):320-32. PubMed ID: 16526022
[TBL] [Abstract][Full Text] [Related]
6. TNFalpha suppression of corneal epithelium migration.
Okada Y; Ikeda K; Yamanaka O; Miyamoto T; Kitano A; Kao WW; Saika S
Mol Vis; 2007 Aug; 13():1428-35. PubMed ID: 17768379
[TBL] [Abstract][Full Text] [Related]
7. [Effect of small interference RNA on E6, E7 mRNA of human papillomavirus type-18 in cervical cancer cells].
Wang P; Cui ZM; Luo B; Lin P
Zhonghua Fu Chan Ke Za Zhi; 2006 Mar; 41(3):190-3. PubMed ID: 16640887
[TBL] [Abstract][Full Text] [Related]
8. Reversal of the malignant phenotype of cervical cancer CaSki cells through adeno-associated virus-mediated delivery of HPV16 E7 antisense RNA.
Wu S; Meng L; Wang S; Wang W; Xi L; Tian X; Chen G; Wu Y; Zhou J; Xu G; Lu Y; Ma D
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2032-7. PubMed ID: 16609012
[TBL] [Abstract][Full Text] [Related]
9. Lack of TNFalpha mRNA expression in cervical cancer is not associated with loss of heterozygosity at 6p21.3, inactivating mutations or promoter methylation.
Kloth JN; Gorter A; ter Haar N; Corver WE; Jordanova ES; Kenter GG; Fleuren GJ
Mol Immunol; 2008 Jan; 45(1):152-9. PubMed ID: 17560652
[TBL] [Abstract][Full Text] [Related]
10. Elevated aromatase expression correlates with cervical carcinoma progression.
Veerapaneni P; Kirma N; Nair HB; Hammes LS; Hall KL; Tekmal RR
Gynecol Oncol; 2009 Sep; 114(3):496-500. PubMed ID: 19555998
[TBL] [Abstract][Full Text] [Related]
11. Angiostatin decreases cell migration and vascular endothelium growth factor (VEGF) to pigment epithelium derived factor (PEDF) RNA ratio in vitro and in a murine ocular melanoma model.
Yang H; Xu Z; Iuvone PM; Grossniklaus HE
Mol Vis; 2006 May; 12():511-7. PubMed ID: 16735992
[TBL] [Abstract][Full Text] [Related]
12. Comparison of TNFalpha and TNFbeta cytolytic mechanisms in human ovarian and cervical carcinoma cell lines.
Powell CB; Scott JH; Collins JL
Gynecol Oncol; 1998 Nov; 71(2):258-65. PubMed ID: 9826469
[TBL] [Abstract][Full Text] [Related]
13. Hydralazine inhibits human cervical cancer cell growth in vitro in association with APC demethylation and re-expression.
Song Y; Zhang C
Cancer Chemother Pharmacol; 2009 Mar; 63(4):605-13. PubMed ID: 18521605
[TBL] [Abstract][Full Text] [Related]
14. [Effects of follicle stimulating hormone on proliferation, apoptosis, migration and invasion of ovarian carcinoma cells: an in vitro experiment].
Huang Y; Zhao YQ; Su M; Gao SJ; Jin HY; Feng YJ
Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(35):2512-4. PubMed ID: 18067819
[TBL] [Abstract][Full Text] [Related]
15. Platelet releasate increases the proliferation and migration of bone marrow-derived cells cultured under osteogenic conditions.
Kark LR; Karp JM; Davies JE
Clin Oral Implants Res; 2006 Jun; 17(3):321-7. PubMed ID: 16672028
[TBL] [Abstract][Full Text] [Related]
16. Intratumor injection of small interfering RNA-targeting human papillomavirus 18 E6 and E7 successfully inhibits the growth of cervical cancer.
Fujii T; Saito M; Iwasaki E; Ochiya T; Takei Y; Hayashi S; Ono A; Hirao N; Nakamura M; Kubushiro K; Tsukazaki K; Aoki D
Int J Oncol; 2006 Sep; 29(3):541-8. PubMed ID: 16865269
[TBL] [Abstract][Full Text] [Related]
17. Dehydroepiandrosterone inhibits the proliferation and induces the death of HPV-positive and HPV-negative cervical cancer cells through an androgen- and estrogen-receptor independent mechanism.
Girón RA; Montaño LF; Escobar ML; López-Marure R
FEBS J; 2009 Oct; 276(19):5598-609. PubMed ID: 19702826
[TBL] [Abstract][Full Text] [Related]
18. [Reversal effect of antisense RNA targeting human papillomavirus 16 (HPV16) E6E7 on malignancy of human cervical cancer cell line SiHa].
Sima N; Wang W; Xu Q; Tian X; Luo AY; Lu YP; Wang SX; Ma D
Ai Zheng; 2007 Jan; 26(1):26-31. PubMed ID: 17222363
[TBL] [Abstract][Full Text] [Related]
19. Epidermal growth factor receptor in cultured human retinal pigment epithelial cells.
Yan F; Hui YN; Li YJ; Guo CM; Meng H
Ophthalmologica; 2007; 221(4):244-50. PubMed ID: 17579290
[TBL] [Abstract][Full Text] [Related]
20. [FAK related non-kinase (FRNK) inhibits migration of a human breast carcinoma cell line MDA-MB-435].
Qin J; Liu ZX
Ai Zheng; 2006 Jul; 25(7):833-8. PubMed ID: 16831273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]